Cbd psychoactive effects

Pro Research Analysisby

Searched over 200M research papers

Analyzed relevant papers

CBD Psychoactive Effects: Key Differences from THC

CBD vs. THC: Psychoactivity and Intoxication

Cannabidiol (CBD) and Δ9-tetrahydrocannabinol (THC) are the two main compounds in cannabis, but they have very different effects on the brain. THC is well known for its psychoactive and intoxicating effects, which cause the "high" associated with cannabis use. In contrast, CBD is generally considered non-intoxicating and does not produce the same mind-altering effects as THC Boggs2017Pintori2023Alves2020+2 MORE.

Direct Psychoactive Properties of CBD

Most research agrees that CBD does not have the classic psychoactive effects seen with THC. CBD does not cause euphoria, significant cognitive impairment, or the typical "high" feeling Boggs2017Pintori2023Alves2020+2 MORE. Instead, CBD is often described as having anxiolytic (anxiety-reducing) and antipsychotic properties, and it is being studied for its potential to help with conditions like anxiety, psychosis, and epilepsy Pintori2023Alves2020Naya2023+1 MORE.

CBD Alone: Mild Intoxicating Effects?

Some studies have found that high doses of CBD alone may show mild intoxicating properties compared to placebo, but these effects are much less pronounced than those of THC. These findings suggest that while CBD is not completely free of psychoactive effects, its impact is subtle and not comparable to the strong intoxication caused by THC .

CBD and THC: Interactions and Modulation of Effects

The interaction between CBD and THC is complex. Some evidence suggests that high doses of CBD can reduce the intoxicating effects of THC, while low doses of CBD may actually enhance THC's psychoactive effects, especially in people who do not use cannabis frequently . Other studies have shown that high doses of CBD can increase the subjective and cognitive effects of THC, rather than reduce them, and do not improve THC's pain-relieving properties . Overall, the way CBD affects THC's psychoactivity depends on the dose and the user's experience with cannabis Solowij2019Gorbenko2024Boggs2017.

Safety and Therapeutic Potential of CBD

CBD is widely regarded as having a good safety profile and is not associated with the harmful psychoactive effects of THC. It is being explored for a range of therapeutic uses, including neurological and psychiatric disorders, without the risk of intoxication or addiction Alves2020Naya2023Schouten2024. However, more research is needed to fully understand its long-term effects, especially in young people .

Conclusion

CBD is not considered psychoactive in the same way as THC and does not produce the classic "high" or significant cognitive impairment. While very high doses of CBD may have mild intoxicating effects, these are minimal compared to THC. The interaction between CBD and THC is dose-dependent, with CBD sometimes reducing and sometimes enhancing THC's psychoactive effects. Overall, CBD is viewed as a non-intoxicating compound with potential therapeutic benefits and a favorable safety profile Solowij2019Gorbenko2024Boggs2017+4 MORE.

Sources and full results

Most relevant research papers on this topic

A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects

Low doses of CBD combined with THC enhance intoxication effects, while high doses of CBD reduce THC's intoxicating effects, with implications for cannabis use recommendations.

RCTRigorous JournalHighly Cited

2019·

150citations

·N. Solowij et al.

European Archives of Psychiatry and Clinical Neuroscience·

DOI

Cannabidiol Increases Psychotropic Effects and Plasma Concentrations of Δ9‐Tetrahydrocannabinol Without Improving Its Analgesic Properties

CBD does not reduce the adverse effects of oral THC or enhance its analgesic properties.

RCT

2024·

14citations

·Andriy A Gorbenko et al.

Clinical Pharmacology & Therapeutics·

DOI

Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol

Cannabidiol (CBD) may interact with THC, potentially reducing anxiety and psychosis-like symptoms, and should be considered in future cannabis-related policy decisions.

Literature ReviewRigorous JournalHighly Cited

2017·

199citations

·D. Boggs et al.

Neuropsychopharmacology·

DOI

THC and CBD: Villain versus Hero? Insights into Adolescent Exposure

Cannabidiol (CBD) has anxiolytic and antipsychotic properties, while THC is psychoactive, and while both compounds have similar effects in the brain, their long-term effects on adolescents are less well-defined.

Literature Review

2023·

38citations

·Nicholas Pintori et al.

International Journal of Molecular Sciences·

DOI

Cannabis sativa: much more beyond Δ9-tetrahydrocannabinol.

CBD and CBDV show potential therapeutic benefits in various medical conditions, but their interactions with CYP450 enzymes and drug efflux transporters may have serious consequences when co-administered with other drugs.

Rigorous JournalHighly Cited

2020·

114citations

·Patrícia Alves et al.

Pharmacological research·

DOI

Molecular and Cellular Mechanisms of Action of Cannabidiol

Cannabidiol (CBD) shows potential in treating various human disorders, including anxiety, chronic pain, psychiatric pathologies, cardiovascular diseases, and cancer, with a safe profile.

Literature ReviewHighly Cited

2023·

110citations

·Nadia Martinez Naya et al.

Molecules·

DOI

Cannabidiol and brain function: current knowledge and future perspectives

CBD shows potential in managing neurological and mental disorders, reducing chronic pain and enhancing cognitive performance.

Literature Review

2024·

32citations

·Moniek Schouten et al.

Frontiers in Pharmacology·

DOI

Current Cannabidiol Safety: A Review.

Cannabidiol (CBD) is a safe and effective treatment for epilepsy, anxiety, acne, pain relief, and has anti-inflammatory properties, despite some mild side effects.

Systematic Review

2022·

14citations

·Neha Minocha et al.

Current drug safety·

DOI

Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research

CBD shows potential as an anxiolytic- and antidepressant-like compound, with potential molecular targets and epigenetic mechanisms playing a role in its therapeutic outcomes.

Literature ReviewHighly Cited

2021·

102citations

·P. A. Melas et al.

International Journal of Molecular Sciences·

DOI

Cannabidiol goes nuclear: The role of PPARγ.

CBD's effects on Alzheimer's, Parkinson's, multiple sclerosis, anxiety, depression, cardiovascular system, immune system, cancer, and adipogenesis are mediated by its PPAR activation.

Systematic Review

2023·

43citations

·Sara Khosropoor et al.

Phytomedicine : international journal of phytotherapy and phytopharmacology·

DOI

Try another search

hawking radiation

type 1 vs type 2 diabetes

antidepressants associated with weight loss

clonidine hydrochloride pharmacology

ptsd treatment approaches

cardiac pathology imaging